Zentalis Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$606.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- Zentalis Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $367.00K.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$973.00K.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $698.00K.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$679.00K.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$2.99M.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$6.22M, a 209.51% decline from fiscal 2023.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $5.68M, a 14.03% decline from fiscal 2022.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $6.61M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$606.00K 10-Q · filed 2026-08-06 | $92.00K derived: sum of 3 quarters · filed 2026-08-06 | -$587.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$973.00K 10-Q · filed 2026-05-12 | -$275.00K derived: sum of 2 quarters · filed 2026-05-12 | -$954.00K derived: sum of 3 quarters · filed 2026-05-12 | -$3.30M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $698.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $19.00K derived: sum of 2 quarters · filed 2026-03-26 | -$2.33M derived: sum of 3 quarters · filed 2026-08-06 | -$2.99M 10-K · filed 2026-03-26 | |||
| 2025-09-30 | -$679.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.03M derived: sum of 2 quarters · filed 2026-08-06 | -$3.69M 10-Q · filed 2025-11-10 | -$3.92M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.01M 10-Q · filed 2026-08-06 | -$3.24M derived: sum of 3 quarters · filed 2026-08-06 | -$8.68M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$663.00K 10-Q · filed 2026-05-12 | -$891.00K derived: sum of 2 quarters · filed 2026-05-12 | -$6.33M derived: sum of 3 quarters · filed 2026-05-12 | -$7.94M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | -$228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$5.67M derived: sum of 2 quarters · filed 2026-03-26 | -$7.27M derived: sum of 3 quarters · filed 2026-03-26 | -$6.22M 10-K · filed 2026-03-26 | |||
| 2024-09-30 | -$5.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$7.05M derived: sum of 2 quarters · filed 2025-11-10 | -$5.99M 10-Q · filed 2025-11-10 | -$5.51M derived: sum of 4 quarters · filed 2026-03-26 | |||
| 2024-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$550.00K 10-Q · filed 2025-08-06 | -$71.00K derived: sum of 3 quarters · filed 2026-03-26 | $1.21M derived: sum of 4 quarters · filed 2026-03-26 | |||
| 2024-03-31 | $1.06M 10-Q · filed 2025-05-14 | $1.53M derived: sum of 2 quarters · filed 2026-03-26 | $2.81M derived: sum of 3 quarters · filed 2026-03-26 | $3.82M derived: sum of 4 quarters · filed 2026-03-26 | |||
| 2023-12-31 | $479.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.76M derived: sum of 2 quarters · filed 2026-03-26 | $2.76M derived: sum of 3 quarters · filed 2026-03-26 | $5.68M 10-K · filed 2026-03-26 | |||
| 2023-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.28M derived: sum of 2 quarters · filed 2024-11-12 | $5.20M 10-Q · filed 2024-11-12 | $7.09M derived: sum of 4 quarters · filed 2025-03-26 | |||
| 2023-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $3.92M 10-Q · filed 2024-08-09 | $5.81M derived: sum of 3 quarters · filed 2025-03-26 | $3.86M derived: sum of 4 quarters · filed 2025-03-26 | |||
| 2023-03-31 | $2.92M 10-Q · filed 2024-05-07 | $4.81M derived: sum of 2 quarters · filed 2025-03-26 | $2.86M derived: sum of 3 quarters · filed 2025-03-26 | $5.37M derived: sum of 4 quarters · filed 2025-03-26 | |||
| 2022-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$58.00K derived: sum of 2 quarters · filed 2025-03-26 | $2.45M derived: sum of 3 quarters · filed 2025-03-26 | $6.61M 10-K · filed 2025-03-26 | |||
| 2022-09-30 | -$1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $562.00K derived: sum of 2 quarters · filed 2023-11-06 | $4.72M 10-Q · filed 2023-11-06 | $4.72M 10-Q · filed 2022-11-09 | $5.12M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $2.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $6.66M 10-Q · filed 2023-08-09 | $7.07M derived: sum of 3 quarters · filed 2024-02-27 | $1.84M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | $4.15M 10-Q · filed 2023-05-10 | $4.56M derived: sum of 2 quarters · filed 2024-02-27 | -$665.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.50M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $402.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$4.82M derived: sum of 2 quarters · filed 2024-02-27 | -$2.65M derived: sum of 3 quarters · filed 2024-02-27 | -$1.29M 10-K · filed 2024-02-27 | -$881.00K 10-K · filed 2022-02-24 | ||
| 2021-09-30 | -$5.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$3.05M derived: sum of 2 quarters · filed 2022-11-09 | -$1.70M 10-Q · filed 2022-11-09 | -$1.68M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.52M 10-Q · filed 2022-08-09 | $3.94M 10-Q · filed 2021-08-12 | $3.54M derived: sum of 3 quarters · filed 2023-03-01 | $4.53M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $1.36M 10-Q · filed 2022-05-05 | $1.37M derived: sum of 2 quarters · filed 2023-03-01 | $2.36M derived: sum of 3 quarters · filed 2023-03-01 | $6.10M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.00M derived: sum of 2 quarters · filed 2023-03-01 | $4.75M derived: sum of 3 quarters · filed 2023-03-01 | $5.80M 10-K · filed 2023-03-01 | $5.52M 10-K · filed 2021-03-25 | ||
| 2020-09-30 | $988.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.73M derived: sum of 2 quarters · filed 2021-11-10 | $5.78M 10-Q · filed 2021-11-10 | $6.46M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $4.80M 10-Q · filed 2021-08-12 | $5.47M derived: sum of 3 quarters · filed 2022-02-24 | $5.92M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $1.05M 10-Q · filed 2021-05-17 | $1.73M derived: sum of 2 quarters · filed 2022-02-24 | $2.17M derived: sum of 3 quarters · filed 2022-02-24 | $2.33M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $675.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.12M derived: sum of 2 quarters · filed 2022-02-24 | $1.28M derived: sum of 3 quarters · filed 2022-02-24 | $1.51M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $603.00K derived: sum of 2 quarters · filed 2020-11-09 | $833.00K 10-Q · filed 2020-11-09 | ||||
| 2019-06-30 | $154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $384.00K 10-Q · filed 2020-08-13 | |||||
| 2019-03-31 | $230.00K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |